Publications

You can use the filters to show only results that match your interests

Filter publications
183 publications by Advisory Council on the Misuse of Drugs ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Response to consultation on cannabis-based medicinal products

    • ACMD
    • Correspondence
  2. Vulnerabilities and substance use: ACMD report

    • ACMD
    • Independent report
  3. Advice on the anticonvulsant drugs Pregabalin and Gabapentin

    • ACMD
    • Correspondence
  4. Further advice on scheduling of cannabis-derived medicinal products

    • ACMD
    • Correspondence
  5. ACMD members' register of interests

    • ACMD
    • Corporate report
  6. Advice on scheduling of cannabis-derived medicinal products

    • ACMD
    • Correspondence
  7. Commission to the ACMD: scheduling under the Misuse of Drugs Regulations 2001

  8. Legitimate use of controlled drugs: research and healthcare

    • ACMD
    • Correspondence
  9. Letter requesting evidence: custody-community transitions

    • ACMD
    • Correspondence
  10. Advice on amending the Misuse of Drugs (Safe Custody) Regulations 1973

    • ACMD
    • Correspondence
  11. Prescribing of controlled drugs by therapeutic radiographers: further advice

    • ACMD
    • Correspondence
  12. ACMD work programme for 2017 to 2019

    • ACMD
    • Correspondence
  13. ACMD letter to the Home Secretary: invitation to the drug strategy board

    • ACMD
    • Correspondence
  14. Commissioning impact on drug treatment

    • ACMD
    • Corporate report
  15. Home Office Science non-departmental public bodies (NDPBs): triennial review

    • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group
    • Corporate report
  16. Psychoactive Substances Bill: evaluation review

    • ACMD
    • Corporate report
  17. Drug strategy 2016: development review

    • ACMD
    • Corporate report
  18. Methiopropamine: a review of the evidence of use and harm

    • ACMD
    • Corporate report
  19. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • ACMD
    • Policy paper
  20. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • Home Office and ACMD
    • Correspondence
  21. Advice on U-47,700, etizolam and other designer benzodiazepines

    • ACMD
    • Correspondence
  22. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • ACMD
    • Correspondence
  23. Misuse of Drugs Regulations 2001: impact on research

    • ACMD
    • Correspondence
  24. Plant cannabinoids: ACMD report

    • ACMD
    • Policy paper
  25. Diversion & illicit supply of medicines

    • ACMD
    • Policy paper
  26. Reducing opioid-related deaths in the UK

    • ACMD
    • Independent report
  27. 'Third generation' synthetic cannabinoids

    • ACMD
    • Correspondence
  28. Temporary class drug order on methiopropamine

    • ACMD
    • Correspondence
  29. Problems for Ageing Drug Users Working Group: public meeting invitation

    • ACMD
    • Promotional material
  30. Independent prescribing of controlled drugs by therapeutic radiographers

    • ACMD
    • Correspondence
  31. ACMD work programme for 2016

    • ACMD
    • Correspondence
  32. ACMD review of alkyl nitrites (poppers)

    • ACMD
    • Correspondence
  33. Advice on the steroid Dienedione

    • ACMD
    • Correspondence
  34. ACMD’s temporary class drug order report on Methiopropamine

    • ACMD
    • Correspondence
  35. ACMD public meeting: 24 November 2015

    • ACMD
    • Form
  36. ACMD’s final advice on definitions for the Psychoactive Substances Bill

    • ACMD
    • Correspondence
  37. How can opioid substitution therapy be optimised to maximise recovery outcomes for service users?

    • ACMD
    • Policy paper
  38. Ministerial response to ACMD report on cocaine misuse

    • DHSC, Home Office and ACMD
    • Correspondence
  39. Ministerial response to ACMD report on nitrous oxide misuse

    • DHSC, Home Office and ACMD
    • Correspondence
  40. ACMD interim advice: diversion and illicit supply of medicines

    • ACMD
    • Correspondence